
View larger version (14K):
[in a new window]
|
A slower progression to disability is demonstrated in the 32 patients with MS carrying the 32CCR5 mutation (solid line), compared with the 224 patients with MS carrying the wild-type CCR5 genotype (broken line) (p < 0.01).
|